WHY IT MATTERS: If you are a parent or caregiver of a teen, or a young person using cannabis yourself, this research reinforces that delaying use until the brain is more fully developed, typically into the mid-20s, is one of the most important harm reduction strategies available. CLINICAL OVERVIEW: Emerging research continues to reinforce what clinicians have observed for years: adolescent cannabis use, particularly during critical neurodevelopmental windows, is associated with a meaningful increase in risk for serious psychiatric conditions including psychotic and bipolar disorders. The developing brain remains uniquely vulnerable to exogenous cannabinoids, and the endocannabinoid system plays a central role in synaptic pruning and neural circuit maturation during the teenage years.
Adolescent Cannabis Use and Psychosis Risk: What This Cohort Study Shows and What It Does Not
A clinician-guided review of a large cohort study examining adolescent past-year cannabis use and subsequent psychiatric diagnoses, including psychosis and bipolar disorder. This article explains what the study measures, what it does not measure, and why causality cannot be assumed despite meaningful association signals.